| Literature DB >> 31447566 |
G L Paniagua-Contreras1, E Monroy-Pérez1, C E Díaz-Velásquez2, A Uribe-García1, A Labastida3, F Peñaloza-Figueroa3, P Domínguez-Trejo4, L R García4, F Vaca-Paniagua2,5,6, S Vaca1.
Abstract
Background : Escherichia coli is the main bacterium associated with urinary tract infections (UTIs), including cystitis and pyelonephritis. Uropathogenic E. coli (UPEC) harbors numerous genes that encode diverse virulence factors contributing to its pathogenicity. The treatment of UTIs has become complicated due to the natural selection of E. coli strains that are multiresistant to several groups of antibiotics regularly used in clinical settings such as hospitals. Genomic reports of the global composition and distribution of the antibiotic resistance and virulence genes of these pathogenic strains are lacking in the Mexican population. Purpose and methods : The aim of this study was to globally characterize the genomes of a group of UPEC strains by massive parallel sequencing to determine the prevalence and distribution of virulence and antibiotic resistance genes associated with different serotypes and phylogenetic groups.Entities:
Keywords: antibiotic resistance genes; virulence genes; whole-genome sequencing
Year: 2019 PMID: 31447566 PMCID: PMC6682767 DOI: 10.2147/IDR.S203661
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Serotypes (O and H antigens), sequence types (STs), phylogenetic group assignations and antibiotic resistance phenotypes. The strains are grouped by their specific combination of serotype and ST
| Sample | Serotype H | Serotype O | Sequence type | Phylogroup | Antibiotic resistance phenotype (no. of strains) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CF | CRO | AM | SXT | CTX | NET | PEF | NF | CL | AK | GE | CB | |||||
| EC022 | H4 | O25 | ST-131 | B2 | R | S | R | R | R | S | R | R | S | S | S | R |
| EC153 | H4 | O25 | ST-131 | B2 | R | S | R | S | R | R | R | S | S | S | R | R |
| EC037 | H4 | O25 | ST-131 | B2 | R | S | R | R | R | S | R | S | R | S | S | R |
| EC131 | H4 | O25 | ST-131 | B2 | R | R | R | R | R | R | R | R | R | S | R | R |
| EC101 | H4 | O25 | ST-131 | B2 | R | R | R | R | R | R | R | S | S | S | R | R |
| EC144 | H4 | O25 | ST-131 | B2 | R | S | R | S | S | S | R | R | S | S | R | R |
| EC307 | H4 | O25 | ST-131 | B2 | R | R | R | S | R | S | R | S | S | S | S | R |
| EC199 | H4 | O25 | ST-131 | B2 | R | S | R | R | S | S | S | S | S | S | S | R |
| EC025 | H4 | O25 | ST-131 | B2 | R | S | R | S | R | R | R | S | S | S | R | R |
| EC053 | H5 | O16 | ST-131 | B2 | R | S | R | R | R | S | R | S | S | R | S | R |
| EC010 | H5 | O75 | ST-1193 | B2 | R | S | R | R | R | S | S | R | S | S | S | R |
| EC102 | H5 | O75 | ST-1193 | B2 | R | R | R | R | R | R | R | S | R | R | R | R |
| EC084 | H5 | O75 | ST-14 | B2 | R | S | R | S | S | S | R | S | R | S | R | R |
| EC112 | H9 | O8 | ST-423 | B1 | R | S | R | R | S | S | R | S | S | S | S | R |
| EC319 | H9 | O8 | ST-423 | B1 | R | R | R | R | R | R | R | S | S | R | R | R |
| EC160 | H9 | O8 | ST-423 | B1 | R | R | R | R | R | R | R | R | R | S | R | R |
| EC167 | H9 | O8 | ST-423 | B1 | R | S | R | R | S | S | S | S | S | S | S | R |
| EC136 | H9 | O8 | ST-423 | B1 | R | R | R | R | R | R | R | R | S | R | R | R |
| EC306 | H11 | O45 | ST-297 | B1 | R | S | R | R | S | S | S | S | S | S | S | R |
| EC151 | H48 | O116 | ST-3519 | B1 | R | R | R | S | R | S | S | S | S | S | S | R |
| EC013 | H4 | O116 | ST-10 | A | R | R | R | R | R | S | R | S | S | R | R | R |
| EC047 | H2 | NA | ST-69 | D | R | R | R | R | R | S | R | S | R | S | S | R |
| EC067 | H18 | O17/O44 | ST-69 | D | R | R | R | R | R | R | R | S | R | R | R | R |
| EC011 | H6 | O1 | ST-648 | NA | R | R | R | S | R | S | R | S | S | S | R | R |
Abbreviations: R, resistant; S, sensitive; Antibiotic: CF, cephalotin; CRO, ceftriaxone; AM, ampicillin; SXT, trimethoprim-sulfamethoxazole; CTX, cefotaxime; NET, netilmicin; PEF, pefloxacin; NF, nitrofurantoin; CL, chloramphenicol; AK, amikacin; GE, gentamycin, CB, carbenicillin.
Numbers and types of genes detected by Prokka and RAST
| Classification | Sample | Prokka | Prokka | Prokka | RAST | RAST | RAST |
|---|---|---|---|---|---|---|---|
| O25:H4 (ST-131) B2 | EC153 | 4951 | 10 | 81 | 5193 | 18 | 80 |
| EC037 | 4948 | 10 | 81 | 5190 | 18 | 80 | |
| EC022 | 4982 | 9 | 81 | 5221 | 16 | 80 | |
| EC131 | 5113 | 10 | 84 | 5368 | 16 | 83 | |
| EC101 | 4962 | 9 | 83 | 5164 | 19 | 83 | |
| EC144 | 5091 | 9 | 81 | 5328 | 16 | 80 | |
| EC307 | 5084 | 9 | 81 | 5321 | 16 | 80 | |
| EC199 | 5010 | 10 | 81 | 5239 | 18 | 80 | |
| EC025 | 4890 | 10 | 80 | 5102 | 17 | 80 | |
| O16:H5 (ST 131) B2 | EC053 | 4651 | 11 | 79 | 4852 | 18 | 79 |
| O75:H5 (ST-1193) B2 | EC010 | 4832 | 8 | 84 | 5085 | 13 | 84 |
| EC102 | 4756 | 8 | 83 | 5002 | 12 | 84 | |
| O75:H5 (ST-14) B2 | EC084 | 4874 | 9 | 84 | 5080 | 11 | 84 |
| O8:H9 (ST-423) B1 | EC112 | 4736 | 8 | 83 | 4922 | 18 | 81 |
| O8:H9 (ST-423) B1 | EC319 | 4737 | 8 | 85 | 4919 | 20 | 83 |
| EC160 | 4737 | 8 | 83 | 4923 | 19 | 81 | |
| EC167 | 4755 | 8 | 84 | 4940 | 20 | 82 | |
| EC136 | 4728 | 8 | 86 | 4919 | 20 | 84 | |
| O45:H11 (ST-297) B1 | EC306 | 4467 | 9 | 78 | 4643 | 17 | 77 |
| O116:H48 (ST-3519) B1 | EC151 | 4418 | 10 | 82 | 4574 | 20 | 80 |
| O16:H4 (ST-10) A | EC013 | 4912 | 8 | 89 | 5119 | 14 | 87 |
| NA:H2 (ST-69) D | EC047 | 5015 | 7 | 83 | 5236 | 16 | 80 |
| O17/O44:H18 (ST-69) D | EC067 | 4826 | 8 | 80 | 5013 | 16 | 78 |
| O1:H6 (ST-648) NA | EC011 | 5010 | 8 | 91 | 5201 | 19 | 92 |
Abbreviation: NA, not available.
Figure 1Occurrence of homologous gene families detected in the 24 UPEC strains. The number of homologous gene families ((y-axis) present in increasing numbers of strains (ranging from presence in at least 1 strain to all 24 strains) is shown. The numbers are displayed separately for the (A) Prokka and (B) RAST annotations. The genes of the cloud, shell, soft-core and core genome are indicated by color.
Figure 2Hierarchical clustering of the strains by gene presence/absence with genes annotated by Prokka and RAST. The pangenome was used for clustering with (A) Prokka and (B) RAST. A distance tree was constructed based on the presence or absence of genes. Samples with a similar gene content clustered together.
Figure 3Average percentage of the contigs (of their genes) of each strain (column labels) that appears in one or more fragments with the same synteny in strain b (row labels). The values for all the comparisons between the 24 UPEC strains and the model strains CFT073 and EC958 ST-131 are shown. The strains were hierarchically clustered according to these values. The phylogroups and serotypes of the strains are indicated at the heatmap margins and in the row and column labels, respectively.
Distribution of antibiotic resistance genes
| Resistance | Serotype | 06:H1:K2 | 025:H4 | 025:H4 | 016:H5 | 075:H5 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene | CFT073 | EC0958 | EC153 | EC037 | EC022 | EC131 | EC101 | EC144 | EC307 | EC199 | EC025 | EC053 | EC010 | |
| Aminoglycoside | aac(3)-lla | – | X | X | X | X | – | X | X | X | X | – | – | |
| Aminoglycoside | aac(3)-lld | – | – | – | – | – | – | – | – | – | – | – | – | |
| Aminoglycoside | aadA1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Aminoglycoside | aadA2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Aminoglycoside | aadA5 | –– | X | X | X | X | X | – | – | – | – | – | X | – |
| Aminoglycoside | aph(3’)-la | – | – | – | – | – | – | – | – | – | – | – | – | |
| Aminoglycoside | strA | – | – | – | – | – | – | – | – | X | – | X | – | |
| Aminoglycoside | strB | – | X | X | X | X | X | – | X | X | X | X | – | |
| Aminoglycoside+ | aac(6’)lb-cr | – | – | – | – | – | X | – | – | – | – | – | X | |
| Fluoroquinolone | ||||||||||||||
| Beta-lactamase | blaCMy-2 | – | – | – | – | – | X | – | – | – | – | – | X | |
| Beta-lactamase | blaCMy-23 | – | X | – | – | – | – | – | – | – | – | – | – | – |
| Beta-lactamase | blaCTX-M-15 | – | X | X | X | X | X | – | X | X | X | X | – | – |
| Beta-lactamase | blaOXA-1 | – | X | X | X | X | X | – | X | X | X | X | – | – |
| Beta-lactamase | blaTEM-1B | – | X | – | – | – | – | – | – | – | X | – | – | – |
| Macrolide | mph(A) | – | X | X | X | X | X | – | X | X | – | – | X | – |
| Phenicol | catA1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Phenicol | catB4 | – | X | X | X | X | X | – | X | X | X | X | – | – |
| Phenicol | flor | – | – | – | – | – | – | – | – | – | – | – | – | |
| Sulphonamide | sul1 | – | X | X | X | X | X | – | X | X | – | – | X | – |
| Sulphonamide | sul2 | – | – | – | – | – | – | – | – | X | – | X | – | |
| Sulphonamide | sul3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Tetracycline | tet(A) | – | X | – | – | – | X | – | – | – | X | X | X | – |
| Tetracycline | tet(B) | – | – | – | – | – | – | – | – | – | – | – | – | |
| Trimethoprim | dfrA1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Trimethoprim | dfrA12 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Trimethoprim | dfrA17 | – | X | X | X | X | X | – | – | – | – | – | X | – |
| Trimethoprim | dfrA5 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Trimethoprim | dfrA8 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Trimethoprim | dfrB4 | – | – | – | – | – | – | X | X | – | – | – | – |
Figure 4Number of virulence factor genes per functional category for the 24 assembled UPEC genomes. The strains are ordered by the phylogroup-ST. Each functional category is color coded.